• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用改良版 Delphi 法确定专家对减少阿片类药物相关伤害最有益和最有害法律的看法。

A modified Delphi process to identify experts' perceptions of the most beneficial and harmful laws to reduce opioid-related harm.

机构信息

Kaiser Permanente Washington Health Research Institute, 1730 Minor Avenue, Seattle, WA, 98101, United States; New York University, Grossman School of Medicine, Center for Opioid Epidemiology and Policy, 180 Madison Ave, 4th Floor, New York City, NY, 10016, United States.

New York University, Grossman School of Medicine, Center for Opioid Epidemiology and Policy, 180 Madison Ave, 4th Floor, New York City, NY, 10016, United States.

出版信息

Int J Drug Policy. 2022 Oct;108:103809. doi: 10.1016/j.drugpo.2022.103809. Epub 2022 Jul 28.

DOI:10.1016/j.drugpo.2022.103809
PMID:35908313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11537719/
Abstract

BACKGROUND

States have enacted multiple types of laws, with a variety of constituent provisions, in response to the opioid epidemic, often simultaneously. This temporal proximity and variation in state-to-state operationalization has resulted in significant challenges for empirical research on their effects. Thus, expert consensus can be helpful to classify laws and their provisions by their degree of helpfulness and impact.

METHODS

We conducted a four-stage modified policy Delphi process to identify the top 10 most helpful and 5 most harmful provisions from eight opioid-related laws. This iterative consultation with six types of opioid experts included a preliminary focus group (n=12), two consecutive surveys (n=56 and n=40, respectively), and a final focus group feedback session (n=5).

RESULTS

On a scale of very harmful (0) to very helpful (4), overdose Good Samaritan laws received the highest average helpfulness rating (3.62, 95% CI: 3.48-3.75), followed by naloxone access laws (3.37, 95% CI: 3.22-3.51), and pain management clinic laws (3.08, 95% CI: 2.89-3.26). Drug-induced homicide (DIH) laws were rated the most harmful (0.88, 95% CI: 0.66-1.11). Impact ratings aligned similarly, although Medicaid laws received the second highest overall impact rating (3.71, 95% CI: 3.45, 3.97). The two most helpful provisions were naloxone standing orders (3.94, 95% CI: 3.86-4.02) and Medicaid coverage of medications for opioid use disorder (MOUD) (3.89, 95% CI: 3.82). Mandatory minimum DIH laws were the most harmful provision (0.73, 95% CI 0.53-0.93); followed by requiring prior authorization for Medicaid coverage of MOUD (1.00 95% CI: 0.72-1.27).

CONCLUSION

Overall, experts rated laws and provisions that facilitated harm reduction efforts and access to MOUD as most helpful. Laws and provisions rated as most harmful criminalized substance use and placed restrictions on access to MOUD. These ratings provide a foundation for evaluating the overall overdose policy environment for each state.

摘要

背景

为应对阿片类药物泛滥问题,各州颁布了多种类型的法律,其中包含各种构成条款,且往往同时颁布。这种在时间上的临近以及各州实施方式的差异,给这些法律效果的实证研究带来了重大挑战。因此,专家共识可以帮助根据其有益程度和影响对法律及其条款进行分类。

方法

我们进行了四阶段的改良政策 Delphi 流程,从八项阿片类相关法律中确定了最有帮助的前 10 项和最有害的 5 项条款。这项咨询涉及六种类型的阿片类专家,包括一个初步的焦点小组(n=12)、两次连续的调查(n=56 和 n=40),以及最后一次焦点小组反馈会议(n=5)。

结果

在非常有害(0)到非常有帮助(4)的评分尺度上,过量用药急救者法案获得了最高的平均有益性评分(3.62,95%置信区间:3.48-3.75),其次是纳洛酮获取法(3.37,95%置信区间:3.22-3.51)和疼痛管理诊所法(3.08,95%置信区间:2.89-3.26)。药物诱发杀人罪(DIH)法被评为最有害(0.88,95%置信区间:0.66-1.11)。影响评分也相似,尽管医疗补助法获得了第二高的总体影响评分(3.71,95%置信区间:3.45,3.97)。最有帮助的两项条款是纳洛酮待命令(3.94,95%置信区间:3.86-4.02)和医疗补助对阿片类药物使用障碍治疗药物的覆盖(3.89,95%置信区间:3.82)。强制性最低 DIH 法是最有害的条款(0.73,95%置信区间 0.53-0.93);其次是要求医疗补助对阿片类药物使用障碍治疗药物的覆盖进行事先授权(1.00 95% CI:0.72-1.27)。

结论

总的来说,专家们认为那些有助于减少伤害和获得阿片类药物使用障碍治疗药物的法律和条款最有帮助。被评为最有害的法律和条款将药物使用定为犯罪,并对获得阿片类药物使用障碍治疗药物的途径施加限制。这些评分结果为评估每个州的整体过量用药政策环境提供了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/11537719/ee8eaff1d674/nihms-1840454-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/11537719/ee8eaff1d674/nihms-1840454-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18db/11537719/ee8eaff1d674/nihms-1840454-f0001.jpg

相似文献

1
A modified Delphi process to identify experts' perceptions of the most beneficial and harmful laws to reduce opioid-related harm.采用改良版 Delphi 法确定专家对减少阿片类药物相关伤害最有益和最有害法律的看法。
Int J Drug Policy. 2022 Oct;108:103809. doi: 10.1016/j.drugpo.2022.103809. Epub 2022 Jul 28.
2
Effectiveness and implementability of state-level naloxone access policies: Expert consensus from an online modified-Delphi process.州级纳洛酮获取政策的有效性和可实施性:在线修改德尔菲法的专家共识。
Int J Drug Policy. 2021 Dec;98:103383. doi: 10.1016/j.drugpo.2021.103383. Epub 2021 Jul 30.
3
Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States.纳洛酮法规促进了美国过量用药教育和纳洛酮分发项目的建立。
Drug Alcohol Depend. 2018 Jul 1;188:370-376. doi: 10.1016/j.drugalcdep.2018.04.004. Epub 2018 May 15.
4
Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.系统评价针对美国阿片类药物流行的国家政策干预措施,2007-2018 年。
JAMA Netw Open. 2021 Feb 1;4(2):e2036687. doi: 10.1001/jamanetworkopen.2020.36687.
5
Do naloxone access laws increase outpatient naloxone prescriptions? Evidence from Medicaid.纳洛酮获取法是否会增加门诊纳洛酮处方?来自医疗补助计划的证据。
Drug Alcohol Depend. 2018 Sep 1;190:37-41. doi: 10.1016/j.drugalcdep.2018.05.014. Epub 2018 Jun 22.
6
Expert views on state-level naloxone access laws: a qualitative analysis of an online modified-Delphi process.专家对州级纳洛酮获取法的看法:在线修改德尔菲法的定性分析。
Harm Reduct J. 2022 Jun 8;19(1):64. doi: 10.1186/s12954-022-00645-1.
7
The Effect of Naloxone Access Laws on Fatal Synthetic Opioid Overdose Fatality Rates.纳洛酮获取法律对致命合成阿片类药物过量死亡率的影响。
J Prim Care Community Health. 2023 Jan-Dec;14:21501319221147246. doi: 10.1177/21501319221147246.
8
Legal requirements and recommendations to prescribe naloxone.合法要求和建议开具纳洛酮处方。
Drug Alcohol Depend. 2020 Apr 1;209:107896. doi: 10.1016/j.drugalcdep.2020.107896. Epub 2020 Feb 6.
9
State variation in opioid treatment policies and opioid-related hospital readmissions.阿片类药物治疗政策的州差异与阿片类药物相关的医院再入院情况。
BMC Health Serv Res. 2018 Dec 17;18(1):971. doi: 10.1186/s12913-018-3703-8.
10
Opioid-overdose laws association with opioid use and overdose mortality.阿片类药物过量法规与阿片类药物使用和过量死亡率的关系。
Addict Behav. 2018 Nov;86:90-95. doi: 10.1016/j.addbeh.2018.03.014. Epub 2018 Mar 19.

引用本文的文献

1
How do restrictions on opioid prescribing, harm reduction, and treatment coverage policies relate to opioid overdose deaths in the United States in 2013-2020? An application of a new state opioid policy scale.2013 - 2020年期间,美国阿片类药物处方限制、减少伤害及治疗覆盖政策与阿片类药物过量死亡之间有何关联?一项新的州阿片类药物政策量表的应用。
Int J Drug Policy. 2025 Mar;137:104713. doi: 10.1016/j.drugpo.2025.104713. Epub 2025 Jan 22.
2
"When people who use drugs can't differentiate between medical care and cops, it's a problem." Compounding risks of law Enforcement Harassment & Punitive Healthcare Policies.“当吸毒者无法区分医疗护理和警察时,这就是个问题了。”这加剧了执法骚扰和惩罚性医疗政策的风险。
Health Justice. 2024 Feb 6;12(1):3. doi: 10.1186/s40352-023-00256-3.
3
Expert Views on State Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder: A Qualitative Analysis of an Online Modified Delphi Process.专家观点:改善阿片类药物使用障碍治疗参与度和保持率的国家政策:在线改良德尔菲法的定性分析。
J Addict Med. 2024;18(2):129-137. doi: 10.1097/ADM.0000000000001253. Epub 2023 Nov 30.

本文引用的文献

1
Racial/Ethnic and Geographic Trends in Combined Stimulant/Opioid Overdoses, 2007-2019.种族/民族和地理趋势与兴奋剂/阿片类药物混合过量有关,2007-2019 年。
Am J Epidemiol. 2022 Mar 24;191(4):599-612. doi: 10.1093/aje/kwab290.
2
Opinion: Public health and police: Building ethical and equitable opioid responses.观点:公共卫生与警方:构建符合伦理道德且公平公正的阿片类药物应对措施。
Proc Natl Acad Sci U S A. 2021 Nov 9;118(45). doi: 10.1073/pnas.2118235118.
3
The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era.美沙酮居家服药方案放宽对 COVID-19 时代治疗效果的影响。
Am J Drug Alcohol Abuse. 2021 Nov 2;47(6):722-729. doi: 10.1080/00952990.2021.1979991. Epub 2021 Oct 20.
4
Drug induced homicide laws may worsen opioid related harms: An example from rural North Carolina.药物诱发杀人罪法律可能会加剧阿片类药物相关危害:以北卡罗来纳州农村地区为例。
Int J Drug Policy. 2021 Nov;97:103406. doi: 10.1016/j.drugpo.2021.103406. Epub 2021 Aug 12.
5
Good Samaritan laws and overdose mortality in the United States in the fentanyl era.好撒玛利亚人法与芬太尼时代美国的过量死亡
Int J Drug Policy. 2021 Nov;97:103294. doi: 10.1016/j.drugpo.2021.103294. Epub 2021 Jun 3.
6
Removal of prior authorization for medication-assisted treatment: impact on opioid use and policy implications in a Medicare Advantage population.取消药物辅助治疗的事先授权:在医疗保险优势人群中对阿片类药物使用的影响及政策意义。
J Manag Care Spec Pharm. 2021 May;27(5):596-606. doi: 10.18553/jmcp.2021.27.5.596.
7
Methodological Challenges and Proposed Solutions for Evaluating Opioid Policy Effectiveness.评估阿片类药物政策有效性的方法学挑战与建议解决方案
Health Serv Outcomes Res Methodol. 2021 Mar;21(1):21-41. doi: 10.1007/s10742-020-00228-2. Epub 2020 Nov 12.
8
Developing interagency collaboration to address the opioid epidemic: A scoping review of joint criminal justice and healthcare initiatives.开展跨部门合作以应对阿片类药物流行:刑事司法与医疗保健联合举措的范围审查
Int J Drug Policy. 2020 Sep;83:102849. doi: 10.1016/j.drugpo.2020.102849. Epub 2020 Jul 9.
9
Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States.美国纳洛酮获取法有效性的新兴文献系统评价。
Addiction. 2021 Jan;116(1):6-17. doi: 10.1111/add.15163. Epub 2020 Jul 8.
10
The effectiveness of drug-related Good Samaritan laws: A review of the literature.药物相关好心人法律的有效性:文献综述。
Int J Drug Policy. 2021 Apr;90:102773. doi: 10.1016/j.drugpo.2020.102773. Epub 2020 May 25.